ClinicalTrialsFinder

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Trials in Meridian, Idaho

1 recruitingMeridian, Idaho

Showing 1–1 of 1 trials

Recruiting
Phase 3

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+12 more
Alliance for Clinical Trials in Oncology382 enrolled786 locationsNCT05677490